Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
A Value Analysis of Y90 Radioembolization vs Transarterial Chemoembolization: An Interview With Joseph Kallini, MD
08/07/2016
Joseph Kallini, MD, is a clinical research fellow at Northwestern University in the department of radiology, section of interventional radiology. His research mentor is Riad Salem MD, MBA, Chief of Interventional Radiology. At the 2016...
Joseph Kallini, MD, is a clinical research fellow at Northwestern University in the department of radiology, section of interventional radiology. His research mentor is Riad Salem MD, MBA, Chief of Interventional Radiology. At the 2016...
Joseph Kallini, MD, is a...
08/07/2016
IO Learning
Clinical Insights
Yttrium-90 Radioembolization of Nonconventional Liver Tumors
07/18/2016
Abstract: Yttrium-90 selective internal radiation therapy (SIRT) is a treatment modality used for unresectable hepatic neoplasm, typically from primary hepatic malignancy such as hepatocellular carcinoma or colorectal and neuroendocrine...
Abstract: Yttrium-90 selective internal radiation therapy (SIRT) is a treatment modality used for unresectable hepatic neoplasm, typically from primary hepatic malignancy such as hepatocellular carcinoma or colorectal and neuroendocrine...
Abstract: Yttrium-90 selective...
07/18/2016
IO Learning
Clinical Insights
Results of the PREMIERE Trial: An Interview With Riad Salem, MD
06/29/2016
Editor's note: See related video here. Riad Salem, MD, chief of interventional radiology at Northwestern University, spoke with Interventional Oncology 360 at the 41st annual scientific meeting of the Society for Interventional Radiology...
Editor's note: See related video here. Riad Salem, MD, chief of interventional radiology at Northwestern University, spoke with Interventional Oncology 360 at the 41st annual scientific meeting of the Society for Interventional Radiology...
Editor's note: See related video...
06/29/2016
IO Learning
Clinical Insights
US RESiN Registry for the Study and Evaluation of Patients Treated With SIR-Spheres
06/29/2016
Abstract: Background: Yttrium-90 (Y90) is increasingly used to treat both primary and secondary liver tumors that are ineligible for resection. In the United States, Y90 resin microspheres (SIR-Spheres; Sirtex Medical) are FDA approved for...
Abstract: Background: Yttrium-90 (Y90) is increasingly used to treat both primary and secondary liver tumors that are ineligible for resection. In the United States, Y90 resin microspheres (SIR-Spheres; Sirtex Medical) are FDA approved for...
Abstract: Background: Yttrium-90...
06/29/2016
IO Learning
Clinical Insights
Cryoablation of Benign and Malignant Breast Tumors
06/21/2016
Abstract: Cryoablation is a well established, FDA approved, minimally invasive treatment modality for fibroadenomas. Additionally, several pilot studies have shown its success in the treatment of small breast cancers. It is an outpatient...
Abstract: Cryoablation is a well established, FDA approved, minimally invasive treatment modality for fibroadenomas. Additionally, several pilot studies have shown its success in the treatment of small breast cancers. It is an outpatient...
Abstract: Cryoablation is a well...
06/21/2016
IO Learning
Clinical Insights
Interventional Oncology Sans Frontières: An Interview With Luigi Solbiati, MD
06/21/2016
The first Interventional Oncology Sans Frontières (IOSF) meeting convened in 2013 in Cernobbio, Italy. The IOSF meeting will convene for the second time in July 2016 in Milan. Interventional Oncology 360 spoke with meeting cofounder Luigi...
The first Interventional Oncology Sans Frontières (IOSF) meeting convened in 2013 in Cernobbio, Italy. The IOSF meeting will convene for the second time in July 2016 in Milan. Interventional Oncology 360 spoke with meeting cofounder Luigi...
The first Interventional...
06/21/2016
IO Learning
Clinical Insights
Imageable Embolic Microsphere Animal Model: An Interview With Robert Abraham, MD, FSIR
05/30/2016
Editor's note: View related video.Robert Abraham, MD, FSIR, is an interventional radiologist with Dalhousie University Department of Diagnostic Imaging in Halifax, Nova Scotia. He and his colleagues undertook a study of imageable embolic...
Editor's note: View related video.Robert Abraham, MD, FSIR, is an interventional radiologist with Dalhousie University Department of Diagnostic Imaging in Halifax, Nova Scotia. He and his colleagues undertook a study of imageable embolic...
Editor's note: View related...
05/30/2016
IO Learning
Clinical Insights
A New Planning Tool for Cryoablation: An Interview With Franz Edward Boas, MD, PhD
05/22/2016
Franz Edward Boas, MD, is an interventional radiologist at Memorial Sloan Kettering Cancer Center. Dr. Boas and his colleagues have developed a tool for planning cryoablation procedures, and he presented details about the tool at the 2016...
Franz Edward Boas, MD, is an interventional radiologist at Memorial Sloan Kettering Cancer Center. Dr. Boas and his colleagues have developed a tool for planning cryoablation procedures, and he presented details about the tool at the 2016...
Franz Edward Boas, MD, is an...
05/22/2016
IO Learning
Clinical Insights
Protective Techniques in Image-Guided Percutaneous Hepatic Ablations
05/09/2016
Abstract: Image-guided percutaneous thermal ablation has become an important tool of the interventionalist for the treatment of patients with hepatic malignancies. This technique has been demonstrated to be safe and effective in most...
Abstract: Image-guided percutaneous thermal ablation has become an important tool of the interventionalist for the treatment of patients with hepatic malignancies. This technique has been demonstrated to be safe and effective in most...
Abstract: Image-guided...
05/09/2016
IO Learning
Clinical Insights
Interventional Treatments for Renal Cell Carcinoma: An Interview With David J. Breen, MRCP, FRCR
04/27/2016
Editor's note: View related video.IO360: What is your experience treating renal cell carcinoma, and what is new in the realm of interventional oncology for renal cell carcinoma?Breen: My unit and my team have been treating renal cell...
Editor's note: View related video.IO360: What is your experience treating renal cell carcinoma, and what is new in the realm of interventional oncology for renal cell carcinoma?Breen: My unit and my team have been treating renal cell...
Editor's note: View related...
04/27/2016
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement